Literature DB >> 24442229

Short-term effectiveness and safety of third-line antiretroviral regimens among patients in Western India.

Sanjay N Pujari1, Abhimanyu Makane, Abhijit Lodha, Vivek Bele, Kedar Joshi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24442229     DOI： 10.1097/QAI.0b013e3182a6104a

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN： 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  3 in total

1.  Regional Challenges in the Prevention of Human Immunodeficiency Virus Drug Resistance.

Authors:  Catherine Godfrey; Marina Bobkova; Charles Boucher; Giovanni Ravasi; Ping Chen; Fujie Zhang; Yasong Wu; Rami Kantor
Journal:  J Infect Dis       Date:  2017-12-01       Impact factor: 7.759

2.  Second-line failure and first experience with third-line antiretroviral therapy in Mumbai, India.

Authors:  Samsuddin Khan; Mrinalini Das; Aristomo Andries; Alaka Deshpande; Homa Mansoor; Peter Saranchuk; Petros Isaakidis
Journal:  Glob Health Action       Date:  2014-07-30       Impact factor: 2.640

3.  Genotyping and outcomes of presumptive second line ART failure cases switched to third line or maintained on second line ART in Mumbai, India.

Authors:  Naresh Gill; Rafael Van den Bergh; Khine Wut Yee Kyaw; Chinmay Laxmeshwar; Mrinalini Das; Sarthak Rastogi; Miriam Arago Galindo; Homa Mansoor; Stobdan Kalon; Petros Isaakidis
Journal:  PLoS One       Date:  2019-11-21       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.